We studied the effects of ketamine and propofol on rat cultured mesangial cell (MC) proliferation.
The 72-h exposure to ketamine (l-100 PM) inhibited
[3H]thymidine incorporation into the MC in a concentrationdependent manner. Propofol, however, was not effective at inhibition of MC proliferation at doses from 1 to 100 PM. Ketamine also decreased the cell number at clinically relevant concentrations and increased adenosine 3',5'-cyclic monophosphate (CAMP) levels in MC. We also studied the effects of ketamine on cytokineinduced [3H]thymidine incorporation into the cells.
Ketamine decreased the tumor necrosis factor-a (TNFa))-, interleukin 1 (IL-l)-, and interleukin 6 (IL-6)-induced [3H]thymidine incorporation into the cells. It also decreased angiotensin II (Ag II)-induced
[3H]thymidine incorporation.
These results suggest that ketamine has inhibitory effects on MC proliferation, but that propofol does not. Because ketamine inhibits TNF-CP, IL-l-, and ILd-induced MC proliferation, it may be useful in suppressing the cell growth clinically. Recently, the number of patients with chronic renal insufficiency has increased, and many of these patients have had surgery (l-3). Although anesthetics should be chosen to protect renal function for these patients, the ideal anesthetic has not been developed to protect renal function.
Mesangial cells (MC), which regulate glomerular blood flow, play a central role in many renal diseases and are associated with the subsequent development of glomerulosclerosis, leading finally to progressive renal failure (4,5). Many cytokines and vasoactive hormones, such as angiotensin II (Ag II), have been identified in the modulation of MC proliferation (6-11). The effects of these cytokines and Ag II on the progress of chronic renal failure have been studied extensively. Recent studies have shown that blood concentrations of cytokines, such as tumor necrosis factor-a (TNF-a), interleukin 1 (IL-l), and interleukin 6 (IL-6), are increased in patients with glomerulonephritis and these cytokines affect the progress of Supported by Grant-in-Aid 07671699 from the Ministry of Education, Science, and Culture of Japan (AS, KM, TS).
Accepted for publication August 14, 1996. Address correspondence and reprint requests to Kayoko Segawa, the Second Department of Internal Medicine, University of Occupational and Environmental Health, School of Medicine, l-l, Iseigaoka, Yahatanishiku, Kitakyushu 807, Japan. chronic renal failure through the proliferation of MC (12,13). Ag II is thought to modulate chronic alternations in glomerular morphology.' Intravenous anesthetics, such as ketamine and propofol, have been used for induction and maintenance of anesthesia. Ketamine is also used for daily dressing changes, debridements, and skin grafting procedures in burn units (15-17). The blood concentrations of cytokines, which affect the MC proliferation, are increased in burn patients (l&19). The effects of ketamine and propofol on MC proliferation have never been investigated. In the present study, we examined the effects of ketamine and propofol on MC proliferation. We also examined the effects of ketamine on cytokine-and Ag II-induced MC proliferation.
Methods

Rat MC Culture
Rat glomerular MC were cultured as described previously (20,21). Briefly, glomeruli were isolated and pre- pared from 100-to 150-g male Wistar rats by the sieving method. Glomeruli were plated on 6-cm dishes (FalconT"; Becton Dickinson Labware, Oxnard, CA) containing RPM1 1640 medium (Nissui, Tokyo, Japan) supplemented with 20% fetal bovine serum (FBS; GIBCO, Grand Island, NY), 50 U/mL penicillin, 50 U / mL streptomycin, and 2 mM L-glutamine. n-Valine was added to the culture instead of L-valine to inhibit the growth of fibroblasts. MC appeared after 7-14 days in culture and reached confluency by Day 21. Confluent cells in cultures were subcultured after detachment with 0.25% trypsin and 1 mM EDTA in phosphate-buffered saline. Cells in the fourth to sixth passages were used in these studies. These cells did not show the morphologic characteristics of macrophages and were stained positively with antifibronectin or antidesmin antibody, but not stained with anticytokeratin or anti-Ia antibody, indicating that these cells were identical to MC.
Assay of L3H1thymidine Incorporation into Rat MC
The assay of [3H]thymidine incorporation into rat MC was as reported previously (21). Rat MC were cultured for 72 h at 37°C (95% 0,/5% CO,) with or without additives in RPM1 1640 containing 4% FBS, in 96-well flat-bottomed microtiter plates (Falcon'r"). The cultures were pulsed with 0.5 PCi of [3H]thymidine (specific activity 6.0 Ci/mmol; Amersham, Buckinghamshire, UK) for the last 12 h of culture. Cells were then harvested with the aid of a semiautomatic cell harvester (Abe Kagaku, Chiba, Japan). The amount of radioactivity incorporated into the DNA in cells was measured with a liquid scintillation spectrophotometer (Aloka LSC-3500ET"; Aloka Co., Tokyo, Japan). Triplicate cultures were used in all assays.
Cell Counts
To verify that the assay for [3H]thymidine incorporation was indicative of the effect of ketamine on actual cell growth, cell numbers were counted. In these experiments lo5 cells/mL were dispensed into Petri dishes and incubated with various concentrations of ketamine for 72 h, after which cells were dispersed with 0.25% trypsin-1 mM EDTA in PBS and counted using a hemocytometer. In separate studies, viability of cell preparations was assessed by trypan blue exclusion at the end of the experimental periods and was found to be > 95% for the cells from both control and experimental cultures. Four separate series of experiments, each done with triplicate cultures, were performed using multiple passages of a batch of mesangial cells. 
Statistical Analysis
Statistical analysis was by either analysis of a linear contrast for trend or by the unpaired t-test. Statistical significance was defined at the P < 0.05 level.
Results
The [3H]thymidine incorporation into the cells to 83.6% 2 5.5%, 80.8% 2 7.8%, and 79.7% +-2.7% of control after 24 h, 48 h, and 72 h, respectively. Therefore, the remaining experiments were performed using the 72-h time point. Figure 2A shows that ketamine inhibited
[3H]thymidine incorporation in a concentration-dependent manner; i.e., [3H]thymidine incorporation was decreased to 89.3% +-3.1%, 79.7% ? 2.7%, and 56.4% 2 2.9% of control by 1 PM, 10 PM, and 100 FM ketamine, respectively.
However, propofol was not significantly different from control on the proliferation of the MC at concentrations of l-100 FM when tested after 72 h incubation (Fig. 2B) . Hence, due to a lack of effect on MC proliferation, we did not use propofol in further experiments.
The Effects of Ketamine on the Cell Number
The inhibitory effects of ketamine on MC proliferation, as assayed by counting the cell number, are shown in Figure 3 . Ketamine suppressed the increase in cell proliferation in a concentration-dependent manner, similar to its ability to inhibit [3H]thymidine incorporation.
Cell numbers were decreased to 59.6% 2 9.5% of control by 10 FM ketamine and to 60.9% + 3.3% of control by 100 J~LM ketamine, respectively (Fig.  3) .
The Effects of Ketamine on CAMP Levels
We next examined the effects of ketamine on CAMP accumulation in MC. Ketamine increased the CAMP levels in the MC in a concentration-dependent manner; i.e., CAMP production increased to 145.3% + 8.3% of control by 10 PM ketamine and to 185.0% ? 21.7% of control by 100 FM ketamine, respectively (Fig. 4) . We examined the effects of the protein kinase A inhibitor, H-7, on the inhibitory effects of ketamine on [3H]thymidine incorporation into MC when both were applied for 72 h. H-7 (3 PM) recovered the inhibitory effects of ketamine to 91.5% ? 2.6% of control (control, 23,002 i-280 cpm; ketamine 10 PM, 18,337 + 626 cpm; P < 0.001; ketamine 10 PM + H-7, 21,041 ? 599 cpm; P = not significant). The Effects of Ketamine on TNF-a-, IL-l-, and IL-g-Induced MC Proliferation
We examined the effects of ketamine on cytokineinduced MC proliferation (Fig. 5) . TNF-a (50 U/mL) increased [3H]thymidine incorporation, corresponding to 115.4% ? 7.5% of control (P < 0.05). Ketamine inhibited TNF-a-induced [3H]thymidine incorporation in a concentration-dependent manner; i.e., [3H]thymidine incorporation was decreased to 84.4% t 5.1% and 70.4% ? 3.1% of the TNF-a-induced ["Hlthymidine incorporation by 10 FM and 100 PM ketamine, respectively (Fig. 5 ). IL-l (100 U/mL) also increased [3H]thymidine incorporation to 140.3% i-8.7% of control (P < 0.005).
[3H]thymidine incorporation was decreased to 89.5% -+ 5.4%, 68.8% + 3.1%, and to 63.9% 2 3.0% of the IL-l-induced [3H]thymidine incorporation by 1 PM, 10 FM, and 100 PM ketamine, respectively (Fig. 5 ). IL-6 (100 U/mL) also increased [3H]thymidine incorporation to 112.4% t 5.0% of control (P < 0.05). This incorporation was decreased to 82.8% -t 5.7% and 70.0% ? 2.3% of the IL-6-induced [3H]thymidine incorporation by 10 PM and 100 PM of ketamine, respectively (Fig. 5) .
The Effects of Ketamine on Ag II-Induced MC Proliferation
We also examined the effects of ketamine on Ag IIinduced MC proliferation. Ag II (1 PM) increased ["Hlthymidine incorporation to 113.4% + 8.0% of control (P < 0.05).
[3H]thymidine incorporation was decreased to 86.1% + 3.7%, 77.5% i-3.5%, and 75.4% + 3.1% of the Ag II-induced [3H]thymidine incorporation by 1 PM, 10 JLLM, and 100 PM ketamine, respectively (Fig. 6) . 
Discussion
Ketamine inhibited the MC proliferation in a concentration-dependent manner. When used clinically, the free plasma concentration of ketamine five minutes after intravenous injection of 2.5 mg/kg was approximately 10.5 PM (22). However, a much larger concentration of ketamine in free plasma (60 PM) was also demonstrated in patients five minutes after the intravenous injection of 2 mg/kg (23). The concentrations of ketamine that inhibited the MC proliferation in this study are comparable to blood concentrations of ketamine seen in clinical anesthesia. There have been many reports on the effects of ketamine on the nervous system (15). However, this is the first report to reveal the inhibitory effects of ketamine on the MC proliferation. This result suggests that ketamine affects not only the nervous system but also the renal system. Although propofol acts as a general anesthetic, it was ineffective at reducing MC proliferation.
We next studied the mechanism of inhibitory effects of ketamine on cell proliferation. Abboud et a1.2 reported that forskolin, an activator of adenylate cyclase, and two analogs of CAMP, dibutyryl-CAMP and In conclusion, we studied the effects of intravenous anesthetics on MC proliferation.
Ketamine inhibited the MC proliferation at clinically relevant concentrations. The activation of the protein kinase A pathway by ketamine may be one of the inhibitory mechanisms of ketamine on MC proliferation.
Ketamine also attenuated the cytokine-and Ag II-induced MC proliferation. Our present results suggest that ketamine has inhibitory effects on MC proliferation. Several investigators have reported on the cytokinemediated enhancement of MC proliferation. TNF-a (8,10), IL-l (6), and IL-6 (7,9) induced the proliferation of MC. TNF-a, IL-l, and IL-6 are released in glomeruli, and these have been identified as autocrine growth factors secreted by the MC (6). In our study, ketamine inhibited the TNF-CP, IL-l-, and IL-6-induced
